rrd181294_205766.html

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GjuBHUJz60mUuf4ria+nbTO52lety1QJ8OjCaH2RXqe1ulOJ/5EKxDFokngGKjsr n1dsJEIN0JPfImR8fwhWHQ== 0001181431-08-038731.txt : 20080613 0001181431-08-038731.hdr.sgml : 20080613 20080613180702 ACCESSION NUMBER: 0001181431-08-038731 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080612 FILED AS OF DATE: 20080613 DATE AS OF CHANGE: 20080613 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STONE DAVID K CENTRAL INDEX KEY: 0001248571 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 08899106 BUSINESS ADDRESS: STREET 1: 24 LIBERTY ST CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 9782638776 4 1 rrd202950.xml FORM 4 X0202 4 2008-06-12 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001248571 STONE DAVID K 1000 WINTER STREET SUITE 2200 WALTHAM MA 02451 1 0 0 0 Common Stock 2008-06-12 4 A 0 300 0.00 A 4850 D Common Stock Options (right to buy) 1.77 2008-06-12 4 A 0 750 0.00 A 2018-06-11 Common Stock 750 750 D Restricted Shares issued under the Company's 2001 Incentive Plan and will vest in equal annual installments over two years. Stock Options issued under the Company's 2001 Incentive Plan and will vest in equal quarterly installments over two years. Stanley F. Chalvire, Esq., Corporate Attorney 2008-06-13 EX-99. 2 rrd181294_205766.htm POWER OF ATTORNEY rrd181294_205766.html

POWER OF ATTORNEY

I hereby constitute and appoint each of Robert E. Farrell, Jr. and Stanley F. Chalvire, Esq.,
signing singly, my true and lawful attorney-in-fact to:

(1) execute for and on my behalf, in my capacity as a director of Oscient Pharmaceuticals
Corporation (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder;

(2) do and perform any and all acts for and on my behalf that may be necessary or desirable
to complete and execute any such Form 3, 4 or 5 and timely file such form with the
United States Securities and Exchange Commiss ion and any stock exchange or similar
authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in
the opinion of such attorney-in-fact, may be to my benefit, in my best interest, or that I
am legally required to do, it being understood that the documents executed by such
attorney-in-fact's discretion.

       I hereby grant to each such attorney-in-fact full power and authority to do and perform
any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and purposes as I might or
could do if personally present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of a ttorney and the rights and powers
herein granted. I acknowledge that the attorneys-in-fact, in serving in such capacity at my
request, are not assuming, nor is the Company assuming, any of my responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

       This Power of Attorney hereby supersedes and revokes any and all Powers of Attorney
previously granted for the purpose of executing for and on my behalf, Company Forms 3, 4 and 5
in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder.

This Power of Attorney shall remain in full force and effect until I am no longer required
to file Forms 3, 4 and 5 with respect to my holdings of and transactions in Company securities,
unless I earlier revoke it in a signed writing delivered to the attorneys-in-fact.

& nbsp; IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed as of this
20th day of September 2007.

                                        _/s/David K. Stone____________________________
                                        David K. Stone
                                        Chairman of the Board and Director

-----END PRIVACY-ENHANCED MESSAGE-----